Treatment of prolymphocytic leukemia
Journal Article
·
· Cancer (Philadelphia); (United States)
DOI:https://doi.org/10.1002/1097-0142(19821101)50:9<1687::AID-CNCR2820500905>3.0.CO;2-I·
OSTI ID:6581569
Prolymphocytic leukemia is characterized by marked splenomegaly, distinctive cellular morphologic characteristics, and a poor clinical course. Five patients with typical PL were treated systematically with vincristine/prednisone, chlorambucil/prednisone, splenic irradiation, splenectomy, and other chemotherapy regimens. No patient responded to vincristine/prednisone. Two patients responded to chlorambucil/prednisone, and four patients had brief responses to splenic irradiation. Two patients underwent splenectomy, one of whom had a prolonged clinical remission. There were no complete remissions. No other chemotherapy combinations were of value. The median survival was 33 months. Recommendations are made to use chlorambucil/prednisone or splenic irradiation as initial treatment. Splenectomy should be considered in patients refractory to these modalities. The course of PL may be more protracted than originally reported.
- Research Organization:
- Department of Medicine, Cornell University Medical College, New York, New York
- OSTI ID:
- 6581569
- Journal Information:
- Cancer (Philadelphia); (United States), Journal Name: Cancer (Philadelphia); (United States) Vol. 50:9; ISSN CANCA
- Country of Publication:
- United States
- Language:
- English
Similar Records
Treatment of prolymphocytic leukemia
Hairy cell leukemia: an unusual lymphoproliferative disease. A study of 24 patients
Combination chemotherapy of lymphomas other than Hodgkin's disease. [Vincristine, prednisone, cyclophosphamide, procarbazine]
Journal Article
·
Sun Oct 31 23:00:00 EST 1982
· Cancer (Philadelphia); (United States)
·
OSTI ID:6342169
Hairy cell leukemia: an unusual lymphoproliferative disease. A study of 24 patients
Conference
·
Tue Aug 01 00:00:00 EDT 1978
· Cancer, Suppl.; (United States)
·
OSTI ID:6621797
Combination chemotherapy of lymphomas other than Hodgkin's disease. [Vincristine, prednisone, cyclophosphamide, procarbazine]
Journal Article
·
Thu Oct 31 23:00:00 EST 1974
· Ann. Intern. Med.; (United States)
·
OSTI ID:5276418
Related Subjects
550600 -- Medicine
550603* -- Medicine-- External Radiation in Therapy-- (1980-)
62 RADIOLOGY AND NUCLEAR MEDICINE
ADRENAL HORMONES
AMINES
ANTINEOPLASTIC DRUGS
BODY
CARBOXYLIC ACIDS
CHEMOTHERAPY
CHLORAMBUCIL
CORTICOSTEROIDS
DISEASES
DRUGS
GLUCOCORTICOIDS
HEMIC DISEASES
HORMONES
HYDROXY COMPOUNDS
KETONES
LEUKEMIA
MEDICINE
MONOCARBOXYLIC ACIDS
NEOPLASMS
NUCLEAR MEDICINE
ORGANIC ACIDS
ORGANIC CHLORINE COMPOUNDS
ORGANIC COMPOUNDS
ORGANIC HALOGEN COMPOUNDS
ORGANS
PATIENTS
PREDNISONE
PREGNANES
RADIOLOGY
RADIOTHERAPY
SPLEEN
SPLENECTOMY
STEROID HORMONES
STEROIDS
SURGERY
THERAPY
550603* -- Medicine-- External Radiation in Therapy-- (1980-)
62 RADIOLOGY AND NUCLEAR MEDICINE
ADRENAL HORMONES
AMINES
ANTINEOPLASTIC DRUGS
BODY
CARBOXYLIC ACIDS
CHEMOTHERAPY
CHLORAMBUCIL
CORTICOSTEROIDS
DISEASES
DRUGS
GLUCOCORTICOIDS
HEMIC DISEASES
HORMONES
HYDROXY COMPOUNDS
KETONES
LEUKEMIA
MEDICINE
MONOCARBOXYLIC ACIDS
NEOPLASMS
NUCLEAR MEDICINE
ORGANIC ACIDS
ORGANIC CHLORINE COMPOUNDS
ORGANIC COMPOUNDS
ORGANIC HALOGEN COMPOUNDS
ORGANS
PATIENTS
PREDNISONE
PREGNANES
RADIOLOGY
RADIOTHERAPY
SPLEEN
SPLENECTOMY
STEROID HORMONES
STEROIDS
SURGERY
THERAPY